Genetics of Bietti Crystalline Dystrophy. Issue 4 (July 2016)

• Record Type: Journal Article
• Authors: Ng, Danny S.C.; Lai, Timothy Y.Y.; Ng, Tsz Kin; Pang, Chi Pui
• Is Part Of: Asia-Pacific journal of ophthalmology. Volume 5:Issue 4(2016)
• Publication Date: 2016-07
• Subjects: Bietti crystalline dystrophy -- retinal dystrophy -- CYP4V2 -- genetics; Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; Periodicals; 617.7005
• DOI: 10.1097/APO.0000000000000209
• Languages: English
• ISSNs: 0129-1653

Abstract

Abstract : Abstract: Bietti crystalline dystrophy (BCD) is an inherited retinal degenerative disease characterized by crystalline deposits in the retina, followed by progressive atrophy of the retinal pigment epithelium (RPE), choriocapillaris, and photoreceptors. CYP4V2 has been identified as the causative gene for BCD. The CYP4V2 gene belongs to the cytochrome P450 superfamily and encodes for fatty acid ω-hydroxylase of both saturated and unsaturated fatty acids. The CYP4V2 protein is localized most abundantly within the endoplasmic reticulum in the RPE and is postulated to play a role in the physiological lipid recycling system between the RPE and photoreceptors to maintain visual function. Electroretinographic assessments have revealed progressive dysfunction of rod and cone photoreceptors in patients with BCD. Several genotypes have been associated with more severe phenotypes based on clinical and electrophysiological findings. With the advent of multimodal imaging with spectral domain optical coherence tomography, fundus autofluorescence, and adaptive optics scanning laser ophthalmoscopy, more precise delineation of BCD severity and progression is now possible, allowing for the potential future development of targets for gene therapy.